Gibbs J P, Murray G, Risler L, Chien J Y, Dev R, Slattery J T
Department of Pharmaceutics, University of Washington, Seattle 98195, USA.
Cancer Res. 1997 Dec 15;57(24):5509-16.
Busulfan, a bifunctional alkylating agent, is a mainstay of myeloablative preparative regimens before hematopoietic stem cell transplantation. The apparent oral clearance of busulfan expressed relative to body surface area is 2-3-fold higher in children 1-4 years old than it is in adults. The first step in busulfan elimination is the formation of a tetrahydrothiophenium ion (THT+) in a glutathione S-transferase-catalyzed reaction. We present computer simulations that demonstrate that the ratio of the AUC of THT+ to that of busulfan over 6 h [(AUC(THT+)/AUC(BU))(0-->6)] is highly correlated (r2 = 0.805) with the determinants of THT+ formation and is virtually independent of the determinants of its elimination (r2 = 0.0201). We compared (AUC(THT+)/AUC(BU))(0-->6) determined in 14 children (0.5-4 years) to that of 11 adults (12-54 years) and found a 1.5-fold elevation in the area ratio (P = 0.0098) and a similarly significant increase in busulfan apparent oral clearance expressed relative to body surface area (P = 0.042). The only common explanation for the elevated busulfan apparent oral clearance and (AUC(THT+)/AUC(BU))(0-->6) is an enhanced ability of children to metabolize busulfan through glutathione conjugation.
白消安是一种双功能烷化剂,是造血干细胞移植前清髓预处理方案的主要药物。相对于体表面积而言,1至4岁儿童白消安的表观口服清除率比成人高2至3倍。白消安消除的第一步是在谷胱甘肽S -转移酶催化的反应中形成四氢噻吩鎓离子(THT +)。我们进行的计算机模拟表明,6小时内THT +的AUC与白消安的AUC之比[(AUC(THT +)/ AUC(BU))(0→6)]与THT +形成的决定因素高度相关(r2 = 0.805),并且实际上与它的消除决定因素无关(r2 = 0.0201)。我们比较了14名儿童(0.5至4岁)和11名成人(12至54岁)的(AUC(THT +)/ AUC(BU))(0→6),发现面积比升高了1.5倍(P = 0.0098),相对于体表面积而言,白消安的表观口服清除率也有类似的显著增加(P = 0.042)。白消安表观口服清除率和(AUC(THT +)/ AUC(BU))(0→6)升高的唯一共同解释是儿童通过谷胱甘肽结合代谢白消安的能力增强。